ASURAGEN
Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.
ASURAGEN
Industry:
Biotechnology Genetics Health Diagnostics Medical
Founded:
2006-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.asuragen.com
Total Employee:
251+
Status:
Active
Contact:
5126815201
Email Addresses:
[email protected]
Total Funding:
80 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager WordPress Domain Not Resolving Mobile Non Scaleable Content Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Remedy Plan Therapeutics
Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.
Current Advisors List
Current Employees Featured
Founder
Investors List
Growth Capital Fund
Growth Capital Fund investment in Series B - Asuragen
Telegraph Hill Partners
Telegraph Hill Partners investment in Series B - Asuragen
PTV Healthcare Capital
PTV Healthcare Capital investment in Series B - Asuragen
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Funding Round - Asuragen
Growth Capital Fund
Growth Capital Fund investment in Series A - Asuragen
Telegraph Hill Partners
Telegraph Hill Partners investment in Series A - Asuragen
Newest Events participated
Official Site Inspections
http://www.asuragen.com Semrush global rank: 1.93 M Semrush visits lastest month: 11.26 K
- Host name: a184-27-6-158.deploy.static.akamaitechnologies.com
- IP address: 184.27.6.158
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
